Department of Ultrasound, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Department of Thyroid Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Front Endocrinol (Lausanne). 2023 May 31;14:1140094. doi: 10.3389/fendo.2023.1140094. eCollection 2023.
Hashimoto's thyroiditis (HT) is a chronic autoimmune disease that poses a risk factor for papillary thyroid carcinoma (PTC). The present study aimed to identify the key genes shared by HT and PTC for advancing the current understanding of their shared pathogenesis and molecular mechanisms.
HT- and PTC-related datasets (GSE138198 and GSE33630, respectively) were retrieved from the Gene Expression Omnibus (GEO) database. Genes significantly related to the PTC phenotype were identified using weighted gene co-expression network analysis (WGCNA). Differentially expressed genes (DEGs) were identified between PTC and healthy samples from GSE33630, and between HT and normal samples from GSE138198. Subsequently, functional enrichment analysis was performed using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Transcription factors and miRNAs regulating the common genes in PTC and HT were forecasted using the Harmonizome and miRWalk databases, respectively, and drugs targeting these genes were investigated using the Drug-Gene Interaction Database (DGIdb). The key genes in both GSE138198 and GSE33630 were further identified Receiver Operating Characteristic (ROC) analysis. The expression of key genes was verified in external validation set and clinical samples using quantitative real-time polymerase chain reaction (qRT-PCR) and immunohistochemistry (IHC).
In total, 690 and 1945 DEGs were associated with PTC and HT, respectively; of these, 56 were shared and exhibited excellent predictive accuracy in the GSE138198 and GSE33630 cohorts. Notably, four genes, Alcohol Dehydrogenase 1B (), Active BCR-related (), alpha-1 antitrypsin (), and lysophosphatidic acid receptor 5 () were recognized as key genes shared by HT and PTC. Subsequently, was identified as a common transcription factor regulating , and expression. These findings were confirmed using qRT-PCR and immunohistochemical analysis.
Four (, and ) out of 56 common genes exhibited diagnostic potential in HT and PTC. Notably, this study, for the first time, defined the close relationship between ABR and HT/PTC progression. Overall, this study provides a basis for understanding the shared pathogenesis and underlying molecular mechanisms of HT and PTC, which might help improve patient diagnosis and prognosis.
桥本甲状腺炎(HT)是一种慢性自身免疫性疾病,是甲状腺乳头状癌(PTC)的一个危险因素。本研究旨在确定 HT 和 PTC 之间共有的关键基因,以加深对它们共同发病机制和分子机制的理解。
从基因表达综合数据库(GEO)中检索了 HT 和 PTC 相关数据集(GSE138198 和 GSE33630)。使用加权基因共表达网络分析(WGCNA)鉴定与 PTC 表型显著相关的基因。从 GSE33630 中鉴定 PTC 与健康样本之间的差异表达基因(DEGs),从 GSE138198 中鉴定 HT 与正常样本之间的 DEGs。随后,使用基因本体论(GO)和京都基因与基因组百科全书(KEGG)进行功能富集分析。使用 Harmonizome 和 miRWalk 数据库分别预测调节 PTC 和 HT 中共同基因的转录因子和 miRNA,使用药物基因相互作用数据库(DGIdb)研究针对这些基因的药物。使用 ROC 分析进一步鉴定 GSE138198 和 GSE33630 中的关键基因。使用定量实时聚合酶链反应(qRT-PCR)和免疫组织化学(IHC)在外部验证集和临床样本中验证关键基因的表达。
共鉴定出与 PTC 和 HT 相关的 690 个和 1945 个 DEGs,其中 56 个是共有的,在 GSE138198 和 GSE33630 队列中具有出色的预测准确性。值得注意的是,有四个基因,即醇脱氢酶 1B ()、活跃的 BCR 相关 ()、α-1 抗胰蛋白酶 () 和溶血磷脂酸受体 5 (),被认为是 HT 和 PTC 共有的关键基因。随后,鉴定出是调节和表达的共同转录因子。这些发现通过 qRT-PCR 和免疫组织化学分析得到了证实。
在 HT 和 PTC 中,共有 56 个基因中的 4 个(、和)具有诊断潜力。值得注意的是,本研究首次定义了 ABR 与 HT/PTC 进展之间的密切关系。总体而言,本研究为理解 HT 和 PTC 的共同发病机制和潜在分子机制提供了基础,这可能有助于改善患者的诊断和预后。